Bull
$18.71
Scenario price
$76.880
-2.037 (-2.65%)At close
Delek US Holdings, Inc. is a diversified downstream energy company with assets in petroleum refining, logistics, pipelines, and renewable fuels. The Company's segments include Refining and Logistics. The Refining segment processes crude oil and other feedstocks for the manufacture of transportation motor fuels, including various grades of gasoline, diesel fuel and aviation fuel, asphalt and other petroleum-based products that are distributed through owned and third-party product terminals. The Refining segment also owns three biodiesel facilities, located in Crossett, Arkansas, Cleburne, Texas and New Albany, Mississippi. The Logistics segment is engaged in gathering, transporting and storing crude oil and natural gas, marketing, distributing, transporting and storing intermediate and refined products and disposing and recycling water in select regions of the southeastern United States and North Dakota, the Midland Basin in Texas, the Delaware Basin in New Mexico and West Texas.
Delek US Holdings Inc is currently priced at $74.51, which is below the average analyst price target of $85.75, indicating potential upside. However, the RSI is at 52.38, suggesting that the stock is neither overbought nor oversold, which is a neutral indicator. The recent downgrade by Mizuho and the mixed analyst ratings suggest caution, as the stock has seen a 150.20% increase year-to-date, which may limit further short-term upside. The main risk is the recent 2.73% decline in price, which indicates volatility.
Mizuho
$83
2026-10-08
Mizuho
2026-10-08
Price Target
$83
Freedom Broker
$86
2026-10-06
Freedom Broker
2026-10-06
Price Target
$86
TD Cowen
$85
2026-10-01
TD Cowen
2026-10-01
Price Target
$85
Raymond James
$90
2026-09-14
Raymond James
2026-09-14
Price Target
$90
TD Cowen
$90
2026-09-14
TD Cowen
2026-09-14
Price Target
$90
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Delek US Holdings Announces $400 Million Convertible Notes Offering

Delek Plans $400 Million Convertible Notes Offering

High-Yield Pipeline Stocks to Consider Amid Energy Demand Surge

Trump Considers Expanding U.S. Refining Capacity Amid Oil Supply Concerns

Delek US Holdings to Join Small-Cap Index, Boosting Visibility
Delek US Holdings, Inc. is a diversified downstream energy company with assets in petroleum refining, logistics, pipelines, and renewable fuels. The Company's segments include Refining and Logistics. The Refining segment processes crude oil and other feedstocks for the manufacture of transportation motor fuels, including various grades of gasoline, diesel fuel and aviation fuel, asphalt and other petroleum-based products that are distributed through owned and third-party product terminals. The Refining segment also owns three biodiesel facilities, located in Crossett, Arkansas, Cleburne, Texas and New Albany, Mississippi. The Logistics segment is engaged in gathering, transporting and storing crude oil and natural gas, marketing, distributing, transporting and storing intermediate and refined products and disposing and recycling water in select regions of the southeastern United States and North Dakota, the Midland Basin in Texas, the Delaware Basin in New Mexico and West Texas. It operates in the Energy sector (PETROLEUM REFINING industry).
Delek US Holdings Inc is currently priced at $74.51, which is below the average analyst price target of $85.75, indicating potential upside. However, the RSI is at 52.38, suggesting that the stock is neither overbought nor oversold, which is a neutral indicator. The recent downgrade by Mizuho and the mixed analyst ratings suggest caution, as the stock has seen a 150.20% increase year-to-date, which may limit further short-term upside. The main risk is the recent 2.73% decline in price, which indicates volatility.
14 analysts cover DK: 8 rate it Buy, 6 Hold and 0 Sell. The average price target is 41.00.
No posts yet
Sign up or log in to join the discussionThis page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.